CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

COVID 19 serologyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug525 COVID 19 Self-Questionnaire Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D007239 Infection NIH 0.05

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease

There is a pandemic in the world by COVID-19. Currently, the pharmacological curative or prophylactic treatments for this infection are not known. Recent studies have suggested that Hydroxy-Chloroquine could be effective in vitro and in vivo against COVID-19. The main objective of this study is to assess in patients with autoimmune disease treated with long course Hydroxy-Chloroquine initiated before the pandemic COVID-19 had an independent protective effect on the risk or the severity of infection with COVID-19.

NCT04481633 COVID-19 Diagnostic Test: COVID 19 serology Other: COVID 19 Self-Questionnaire
MeSH:Infection

Primary Outcomes

Description: Rate of patients with positive anti-COVID19 serology with or without Hydroxy-Chloroquine.

Measure: Rate of patients with positive anti-COVID19 serology

Time: Day 1

Secondary Outcomes

Description: Rate of patients with symptomatic or severe (hospitalization) form of infection.

Measure: Rate of patients with symptomatic or severe (hospitalization) form of infection

Time: Day 1

No related HPO nodes (Using clinical trials)